SEC Filings

Filing date	Form	Description	View
03/09/20	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000834237-20-009221.pdf 0000834237-20-009221.rtf
03/04/20	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-20-029209.pdf 0001104659-20-029209.rtf 0001104659-20-029209.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
03/03/20	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001104659-20-028602.pdf 0001104659-20-028602.rtf 0001104659-20-028602.xls
02/27/20	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001387131-20-002259.pdf 0001387131-20-002259.rtf 0001387131-20-002259.xls
02/27/20	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001558370-20-001644.pdf 0001558370-20-001644.rtf 0001558370-20-001644.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/24/20	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-20-024258.pdf 0001104659-20-024258.rtf 0001104659-20-024258.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002141.pdf 0001179110-20-002141.rtf 0001179110-20-002141.xls
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002143.pdf 0001179110-20-002143.rtf 0001179110-20-002143.xls
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002150.pdf 0001179110-20-002150.rtf 0001179110-20-002150.xls
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002152.pdf 0001179110-20-002152.rtf 0001179110-20-002152.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.